WallStreetZenWallStreetZen

NASDAQ: SOPH
Sophia Genetics Sa Stock Forecast, Predictions & Price Target

Open Broker Account

Analyst price target for SOPH

Based on 2 analysts offering 12 month price targets for Sophia Genetics Sa.
Min Forecast
$2.00-11.89%
Avg Forecast
$7.00+208.37%
Max Forecast
$12.00+428.63%

Should I buy or sell SOPH stock?

Based on 2 analysts offering ratings for Sophia Genetics Sa.
Buy
Strong Buy
1 analysts 50%
Buy
0 analysts 0%
Hold
1 analysts 50%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their SOPH stock forecasts and price targets.

SOPH stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Credit Suisse
Bottom 5%
5
HoldInitiates Coverage On$2.00-11.89%2022-11-23
Morgan Stanley
Bottom 5%
5
Strong BuyMaintains$12.00+428.63%2022-11-09
Anonymous
Morgan Stanley
Strong BuyMaintains$17.00+648.90%2022-03-16

1 of 1

Forecast return on equity

Is SOPH forecast to generate an efficient return?
Company
25.55%
Industry
12.17%
Market
64.75%
SOPH's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is SOPH forecast to generate an efficient return on assets?
Company
20.99%
Industry
9.22%
SOPH is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

SOPH earnings per share forecast

What is SOPH's earnings per share in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
-$1.47
Avg 2 year Forecast
-$1.26
Avg 3 year Forecast
-$1.00

SOPH revenue forecast

What is SOPH's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$47.6M+5.58%
Avg 2 year Forecast
$64.2M+42.39%
Avg 3 year Forecast
$94.8M+110.05%
SOPH's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

SOPH revenue growth forecast

How is SOPH forecast to perform vs Health Information Services companies and vs the US market?
Company
26.6%
Industry
15.54%
Market
6.76%
SOPH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SOPH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SOPH vs Health Information Service Stocks

TickerPricePrice TargetUp/downsideConsensus
SOPH$2.27$7.00+208.37%Buy
SMFR$0.40$2.67+568.42%Buy
TRHC$4.49$8.30+84.86%Buy
FORA$2.94$13.00+342.18%Strong Buy
STRM$1.92$3.00+56.25%Strong Buy

Sophia Genetics Sa Stock Forecast FAQ

Is Sophia Genetics Sa Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: SOPH) stock is to Buy SOPH stock.

Out of 2 analysts, 1 (50%) are recommending SOPH as a Strong Buy, 0 (0%) are recommending SOPH as a Buy, 1 (50%) are recommending SOPH as a Hold, 0 (0%) are recommending SOPH as a Sell, and 0 (0%) are recommending SOPH as a Strong Sell.

If you're new to stock investing, here's how to buy Sophia Genetics Sa stock.

What is SOPH's earnings growth forecast for 2022-2024?

(NASDAQ: SOPH) Sophia Genetics Sa's forecast annual earnings growth rate of N/A is not forecast to beat the US Health Information Services industry's average forecast earnings growth rate of 11.37%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 16.96%.

Sophia Genetics Sa's earnings in 2022 is -$94,852,000.On average, 2 Wall Street analysts forecast SOPH's earnings for 2022 to be -$94,305,967, with the lowest SOPH earnings forecast at -$98,796,727, and the highest SOPH earnings forecast at -$89,173,669. On average, 2 Wall Street analysts forecast SOPH's earnings for 2023 to be -$80,833,686, with the lowest SOPH earnings forecast at -$86,607,521, and the highest SOPH earnings forecast at -$75,059,851.

In 2024, SOPH is forecast to generate -$64,153,719 in earnings, with the lowest earnings forecast at -$69,927,554 and the highest earnings forecast at -$58,379,884.

What is SOPH's revenue growth forecast for 2022-2024?

(NASDAQ: SOPH) Sophia Genetics Sa's forecast annual revenue growth rate of 26.6% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 15.54%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 6.76%.

Sophia Genetics Sa's revenue in 2022 is $45,113,000.On average, 3 Wall Street analysts forecast SOPH's revenue for 2022 to be $3,055,769,943, with the lowest SOPH revenue forecast at $3,021,640,165, and the highest SOPH revenue forecast at $3,084,895,732. On average, 3 Wall Street analysts forecast SOPH's revenue for 2023 to be $4,121,042,447, with the lowest SOPH revenue forecast at $3,932,622,975, and the highest SOPH revenue forecast at $4,272,637,685.

In 2024, SOPH is forecast to generate $6,079,270,566 in revenue, with the lowest revenue forecast at $6,027,883,437 and the highest revenue forecast at $6,130,721,849.

What is SOPH's forecast return on assets (ROA) for 2022-2025?

(NASDAQ: SOPH) forecast ROA is 20.99%, which is higher than the forecast US Health Information Services industry average of 9.22%.

What is SOPH's Price Target?

According to 2 Wall Street analysts that have issued a 1 year SOPH price target, the average SOPH price target is $7.00, with the highest SOPH stock price forecast at $12.00 and the lowest SOPH stock price forecast at $2.00.

On average, Wall Street analysts predict that Sophia Genetics Sa's share price could reach $7.00 by Nov 23, 2023. The average Sophia Genetics Sa stock price prediction forecasts a potential upside of 208.37% from the current SOPH share price of $2.27.

What is SOPH's Earnings Per Share (EPS) forecast for 2022-2024?

(NASDAQ: SOPH) Sophia Genetics Sa's current Earnings Per Share (EPS) is -$1.48. On average, analysts forecast that SOPH's EPS will be -$1.47 for 2022, with the lowest EPS forecast at -$1.54, and the highest EPS forecast at -$1.39. On average, analysts forecast that SOPH's EPS will be -$1.26 for 2023, with the lowest EPS forecast at -$1.35, and the highest EPS forecast at -$1.17. In 2024, SOPH's EPS is forecast to hit -$1.00 (min: -$1.09, max: -$0.91).

What is SOPH's forecast return on equity (ROE) for 2022-2025?

(NASDAQ: SOPH) forecast ROE is 25.55%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.